Skip to main content
All lobbying filings

The McManus Group

The McManus Group filed a Q3 report for Medical Device Manufacturers Association on October 20, 2026, reporting $30,000 in lobbying income.

Lobbying for Medical Device Manufacturers Association · Trade association for medical device manufacturers

As filed: THE MCMANUS GROUP for MEDICAL DEVICE MANUFACTURERS ASSOCIATION.

All filings by The McManus Group · Everything Medical Device Manufacturers Association has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC), including H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Access to and reimbursement of medical devices in Medicare program.

Trade (domestic/foreign)

Issues related to global trade and tariffs.

 Bills named in this filing 2
  • H.R. 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S. 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem